ESC 365 - Impact of alirocumab treatment on renal function

ESC Premium Access

Impact of alirocumab treatment on renal function

Session: Poster session 1 - Cardiovascular cell biology

Topic: Lipids

Speaker: Professor P. Toth (Baltimore, US)

Event: ESC Congress 2016

Congress Presentation

About the speaker

Professor Peter Toth

CGH Medical Center and The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore (United States of America)

5 presentations

0 follower

15 more presentations in this session

The validity of a novel method for estimating low-density lipoprotein cholesterol levels in diabetic patients

Speaker: Doctor H. Chaen (Kagoshima, JP)

Serum lipoprotein (a) is associated with the presence of ruptured plaque determined by optical coherence tomography in coronary artery disease.

Speaker: Doctor S. Sakai (Tsukuba, JP)

Decreased circulating omega-6 fatty acid levels are associated with total mortality in patients admitted to cardiac intensive care unit

Speaker: Doctor S. Ouhi (Tokyo, JP)

Pitavastatin lowers plasma levels of CoQ10 less than equipotent doses of rosuvastatin or atorvastatin

Speaker: Doctor P. Moriarty (Kansas City, US)

MicroRNA-19a reduces thrombogenicity in diabetes via targeting of tissue factor

Speaker: Doctor M. Witkowski (Berlin, DE)

Access the full session

Poster session 1 - Cardiovascular cell biology

Speakers: Professor P. Toth, Doctor H. Chaen, Doctor S. Sakai, Doctor S. Ouhi, Doctor P. Moriarty...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources